Lyra Therapeutics, Inc. LYRA

Full chart Compare
Set alert

Price alert · LYRA

All alert types
0.19 USD 0.00 (+0.00%)

At closeNov 2, 2026, 4:00 PM EST

0.35 +0.16 +84.47%

After hours · Nov 2, 4:00 PM ET

0.3623 Day range 0.52
0.0004 52-week range 5.72
YTD
-93.83%
1 year
-96.56%

Analyst view

Price target (mean) 1.25 +557.9% upside
Target (low)
0.50
Target (mean)
1.25
Target (high)
2.00
Ratings (0m) 5 1 buy · 4 hold · 0 sell
  • Strong buy0
  • Buy1
  • Hold4
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 5
  • 1 month ago 4

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

LYRA analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.13-0.13 – -0.13-0.1955+33.5%204.80K+40.3%1
Next quarter0.000.00 – 0.000.000.0%0-100.0%0
Current year-1.28-1.39 – -1.16-1.23-4.0%1.52M-2.5%2
Next year-0.945-1.03 – -0.86-1.28+25.9%781.60K-48.5%2

Upgrades and downgrades

The latest rating changes

LYRA analyst upgrades and downgrades
DateFirmActionFromTo
Aug 15, 2024Cantor FitzgeraldReiterated—Overweight
Aug 15, 2024HC Wainwright & Co.ReiteratedNeutralNeutral
Jun 20, 2024Cantor FitzgeraldReiterated—Overweight
May 7, 2024HC Wainwright & Co.DowngradeBuyNeutral
May 7, 2024JefferiesDowngradeBuyHold
May 6, 2024BTIGDowngradeBuyNeutral
May 1, 2024HC Wainwright & Co.ReiteratedBuyBuy
Mar 25, 2024B of A SecuritiesMaintainedBuyBuy
Mar 22, 2024HC Wainwright & Co.ReiteratedBuyBuy
Oct 2, 2023HC Wainwright & Co.ReiteratedBuyBuy
Sep 12, 2023B of A SecuritiesMaintainedBuyBuy
Aug 31, 2023HC Wainwright & Co.Initiated—Buy
Feb 7, 2023BTIGMaintained—Buy
May 24, 2022Cantor FitzgeraldInitiated—Overweight
May 26, 2020B of A SecuritiesInitiated—Buy
May 26, 2020JefferiesInitiated—Buy